Contrast Enhanced SWI for Carotid Plaque Imaging
Contrast Enhanced Susceptibility Weighted Imaging (SWI) for Characterization of Carotid Plaque
1 other identifier
observational
25
1 country
2
Brief Summary
This study aims to compare image-based characteristics of carotid walls between symptomatic side and the opposite side. The design of this study is phase IV, prospective observational study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2016
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2016
CompletedFirst Posted
Study publicly available on registry
April 25, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedSeptember 18, 2019
September 1, 2019
3.3 years
April 19, 2016
September 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection rate of findings of vulnerable carotid plaque
within 3 days after enrollment
Secondary Outcomes (1)
Accuracy in delinating geometry of carotid inner lumen and outer wall
within 3 days after enrollment
Study Arms (1)
Patients with acute or recent (within 3months) stroke
Interventions
Eligibility Criteria
Patients with acute or recent (within 3months) stroke or TIA (transient ischaemic attack)
You may qualify if:
- Patients with acute or recent (within 3months) stroke or TIA
- % stenosis of internal carotid artery by NASCET criteria
- Written informed consent, prior to registration
You may not qualify if:
- Hemorrhagic stroke
- Previous history of carotid endarterectomy (CEA), angioplasty, or stenting
- Contraindication for MR imaging
- Hypersensitivity to gadolinium based contrast media
- Pregnant or lactating women
- Patients under age of 19-year-old
- Renal condition : eGFR \< 60
- Patients unable and/or unwilling to comply with treatment or study instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Asan Medical Center
Seoul, South Korea
Seoul St. Mary's Hospital
Seoul, South Korea
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
April 19, 2016
First Posted
April 25, 2016
Study Start
August 1, 2016
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
September 18, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share